首页 正文

Risk of CKD in biopsy-proven metabolic dysfunction-associated steatotic liver disease

{{output}}
Background and hypothesis: There is scarce long-term data on the risk of chronic kidney disease (CKD) in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease (MASLD). We hypothesize that the risk o... ...